Pharma & Healthcare
Global Janus Kinase inhibitors (JAKi) Market Research Report 2026
- May 01, 26
- ID: 748661
- Pages: 93
- Figures: 106
- Views: 7
This report delivers a comprehensive overview of the global Janus Kinase inhibitors (JAKi) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Janus Kinase inhibitors (JAKi). The Janus Kinase inhibitors (JAKi) market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Janus Kinase inhibitors (JAKi) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Janus Kinase inhibitors (JAKi) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Eli Lilly and Co.
Pfizer Inc.
AbbVie
Galapagos NV
Segment by Type
Tofacitinib
Abrocitinib
Baricitinib
Upadacitinib
Filgotinib
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Janus Kinase inhibitors (JAKi) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Janus Kinase inhibitors (JAKi) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Janus Kinase inhibitors (JAKi) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Janus Kinase inhibitors (JAKi) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Eli Lilly and Co.
Pfizer Inc.
AbbVie
Galapagos NV
Segment by Type
Tofacitinib
Abrocitinib
Baricitinib
Upadacitinib
Filgotinib
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Janus Kinase inhibitors (JAKi) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Janus Kinase inhibitors (JAKi) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Janus Kinase inhibitors (JAKi) Market Overview
1.1 Product Definition
1.2 Janus Kinase inhibitors (JAKi) by Type
1.2.1 Global Janus Kinase inhibitors (JAKi) Market Value by Type: 2025 vs 2032
1.2.2 Tofacitinib
1.2.3 Abrocitinib
1.2.4 Baricitinib
1.2.5 Upadacitinib
1.2.6 Filgotinib
1.3 Janus Kinase inhibitors (JAKi) by Application
1.3.1 Global Janus Kinase inhibitors (JAKi) Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Janus Kinase inhibitors (JAKi) Market Size Estimates and Forecasts
1.4.1 Global Janus Kinase inhibitors (JAKi) Revenue 2021–2032
1.4.2 Global Janus Kinase inhibitors (JAKi) Sales 2021–2032
1.4.3 Global Janus Kinase inhibitors (JAKi) Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Janus Kinase inhibitors (JAKi) Market Competition by Manufacturers
2.1 Global Janus Kinase inhibitors (JAKi) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Janus Kinase inhibitors (JAKi) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Janus Kinase inhibitors (JAKi), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Janus Kinase inhibitors (JAKi), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Janus Kinase inhibitors (JAKi), Product Types and Applications
2.7 Global Key Manufacturers of Janus Kinase inhibitors (JAKi), Date of Entry into the Industry
2.8 Global Janus Kinase inhibitors (JAKi) Market Competitive Situation and Trends
2.8.1 Global Janus Kinase inhibitors (JAKi) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Janus Kinase inhibitors (JAKi) Players Market Share by Revenue
2.8.3 Global Janus Kinase inhibitors (JAKi) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Janus Kinase inhibitors (JAKi) Market Scenario by Region
3.1 Global Janus Kinase inhibitors (JAKi) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Janus Kinase inhibitors (JAKi) Sales by Region: 2021–2032
3.2.1 Global Janus Kinase inhibitors (JAKi) Sales by Region: 2021–2026
3.2.2 Global Janus Kinase inhibitors (JAKi) Sales by Region: 2027–2032
3.3 Global Janus Kinase inhibitors (JAKi) Revenue by Region: 2021–2032
3.3.1 Global Janus Kinase inhibitors (JAKi) Revenue by Region: 2021–2026
3.3.2 Global Janus Kinase inhibitors (JAKi) Revenue by Region: 2027–2032
3.4 North America Janus Kinase inhibitors (JAKi) Market Facts & Figures by Country
3.4.1 North America Janus Kinase inhibitors (JAKi) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Janus Kinase inhibitors (JAKi) Sales by Country (2021–2032)
3.4.3 North America Janus Kinase inhibitors (JAKi) Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Janus Kinase inhibitors (JAKi) Market Facts & Figures by Country
3.5.1 Europe Janus Kinase inhibitors (JAKi) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Janus Kinase inhibitors (JAKi) Sales by Country (2021–2032)
3.5.3 Europe Janus Kinase inhibitors (JAKi) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Janus Kinase inhibitors (JAKi) Market Facts & Figures by Region
3.6.1 Asia Pacific Janus Kinase inhibitors (JAKi) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Janus Kinase inhibitors (JAKi) Sales by Region (2021–2032)
3.6.3 Asia Pacific Janus Kinase inhibitors (JAKi) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Janus Kinase inhibitors (JAKi) Market Facts & Figures by Country
3.7.1 Latin America Janus Kinase inhibitors (JAKi) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Janus Kinase inhibitors (JAKi) Sales by Country (2021–2032)
3.7.3 Latin America Janus Kinase inhibitors (JAKi) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Janus Kinase inhibitors (JAKi) Market Facts & Figures by Country
3.8.1 Middle East and Africa Janus Kinase inhibitors (JAKi) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Janus Kinase inhibitors (JAKi) Sales by Type (2021–2032)
4.1.1 Global Janus Kinase inhibitors (JAKi) Sales by Type (2021–2026)
4.1.2 Global Janus Kinase inhibitors (JAKi) Sales by Type (2027–2032)
4.1.3 Global Janus Kinase inhibitors (JAKi) Sales Market Share by Type (2021–2032)
4.2 Global Janus Kinase inhibitors (JAKi) Revenue by Type (2021–2032)
4.2.1 Global Janus Kinase inhibitors (JAKi) Revenue by Type (2021–2026)
4.2.2 Global Janus Kinase inhibitors (JAKi) Revenue by Type (2027–2032)
4.2.3 Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Type (2021–2032)
4.3 Global Janus Kinase inhibitors (JAKi) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Janus Kinase inhibitors (JAKi) Sales by Application (2021–2032)
5.1.1 Global Janus Kinase inhibitors (JAKi) Sales by Application (2021–2026)
5.1.2 Global Janus Kinase inhibitors (JAKi) Sales by Application (2027–2032)
5.1.3 Global Janus Kinase inhibitors (JAKi) Sales Market Share by Application (2021–2032)
5.2 Global Janus Kinase inhibitors (JAKi) Revenue by Application (2021–2032)
5.2.1 Global Janus Kinase inhibitors (JAKi) Revenue by Application (2021–2026)
5.2.2 Global Janus Kinase inhibitors (JAKi) Revenue by Application (2027–2032)
5.2.3 Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Application (2021–2032)
5.3 Global Janus Kinase inhibitors (JAKi) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Eli Lilly and Co.
6.1.1 Eli Lilly and Co. Company Information
6.1.2 Eli Lilly and Co. Description and Business Overview
6.1.3 Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Product Portfolio
6.1.5 Eli Lilly and Co. Recent Developments/Updates
6.2 Pfizer Inc.
6.2.1 Pfizer Inc. Company Information
6.2.2 Pfizer Inc. Description and Business Overview
6.2.3 Pfizer Inc. Janus Kinase inhibitors (JAKi) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pfizer Inc. Janus Kinase inhibitors (JAKi) Product Portfolio
6.2.5 Pfizer Inc. Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Company Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Janus Kinase inhibitors (JAKi) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 AbbVie Janus Kinase inhibitors (JAKi) Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Galapagos NV
6.4.1 Galapagos NV Company Information
6.4.2 Galapagos NV Description and Business Overview
6.4.3 Galapagos NV Janus Kinase inhibitors (JAKi) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Galapagos NV Janus Kinase inhibitors (JAKi) Product Portfolio
6.4.5 Galapagos NV Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Janus Kinase inhibitors (JAKi) Industry Chain Analysis
7.2 Janus Kinase inhibitors (JAKi) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Janus Kinase inhibitors (JAKi) Production Mode & Process Analysis
7.4 Janus Kinase inhibitors (JAKi) Sales and Marketing
7.4.1 Janus Kinase inhibitors (JAKi) Sales Channels
7.4.2 Janus Kinase inhibitors (JAKi) Distributors
7.5 Janus Kinase inhibitors (JAKi) Customer Analysis
8 Janus Kinase inhibitors (JAKi) Market Dynamics
8.1 Janus Kinase inhibitors (JAKi) Industry Trends
8.2 Janus Kinase inhibitors (JAKi) Market Drivers
8.3 Janus Kinase inhibitors (JAKi) Market Challenges
8.4 Janus Kinase inhibitors (JAKi) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Janus Kinase inhibitors (JAKi) by Type
1.2.1 Global Janus Kinase inhibitors (JAKi) Market Value by Type: 2025 vs 2032
1.2.2 Tofacitinib
1.2.3 Abrocitinib
1.2.4 Baricitinib
1.2.5 Upadacitinib
1.2.6 Filgotinib
1.3 Janus Kinase inhibitors (JAKi) by Application
1.3.1 Global Janus Kinase inhibitors (JAKi) Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Janus Kinase inhibitors (JAKi) Market Size Estimates and Forecasts
1.4.1 Global Janus Kinase inhibitors (JAKi) Revenue 2021–2032
1.4.2 Global Janus Kinase inhibitors (JAKi) Sales 2021–2032
1.4.3 Global Janus Kinase inhibitors (JAKi) Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Janus Kinase inhibitors (JAKi) Market Competition by Manufacturers
2.1 Global Janus Kinase inhibitors (JAKi) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Janus Kinase inhibitors (JAKi) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Janus Kinase inhibitors (JAKi), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Janus Kinase inhibitors (JAKi), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Janus Kinase inhibitors (JAKi), Product Types and Applications
2.7 Global Key Manufacturers of Janus Kinase inhibitors (JAKi), Date of Entry into the Industry
2.8 Global Janus Kinase inhibitors (JAKi) Market Competitive Situation and Trends
2.8.1 Global Janus Kinase inhibitors (JAKi) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Janus Kinase inhibitors (JAKi) Players Market Share by Revenue
2.8.3 Global Janus Kinase inhibitors (JAKi) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Janus Kinase inhibitors (JAKi) Market Scenario by Region
3.1 Global Janus Kinase inhibitors (JAKi) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Janus Kinase inhibitors (JAKi) Sales by Region: 2021–2032
3.2.1 Global Janus Kinase inhibitors (JAKi) Sales by Region: 2021–2026
3.2.2 Global Janus Kinase inhibitors (JAKi) Sales by Region: 2027–2032
3.3 Global Janus Kinase inhibitors (JAKi) Revenue by Region: 2021–2032
3.3.1 Global Janus Kinase inhibitors (JAKi) Revenue by Region: 2021–2026
3.3.2 Global Janus Kinase inhibitors (JAKi) Revenue by Region: 2027–2032
3.4 North America Janus Kinase inhibitors (JAKi) Market Facts & Figures by Country
3.4.1 North America Janus Kinase inhibitors (JAKi) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Janus Kinase inhibitors (JAKi) Sales by Country (2021–2032)
3.4.3 North America Janus Kinase inhibitors (JAKi) Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Janus Kinase inhibitors (JAKi) Market Facts & Figures by Country
3.5.1 Europe Janus Kinase inhibitors (JAKi) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Janus Kinase inhibitors (JAKi) Sales by Country (2021–2032)
3.5.3 Europe Janus Kinase inhibitors (JAKi) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Janus Kinase inhibitors (JAKi) Market Facts & Figures by Region
3.6.1 Asia Pacific Janus Kinase inhibitors (JAKi) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Janus Kinase inhibitors (JAKi) Sales by Region (2021–2032)
3.6.3 Asia Pacific Janus Kinase inhibitors (JAKi) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Janus Kinase inhibitors (JAKi) Market Facts & Figures by Country
3.7.1 Latin America Janus Kinase inhibitors (JAKi) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Janus Kinase inhibitors (JAKi) Sales by Country (2021–2032)
3.7.3 Latin America Janus Kinase inhibitors (JAKi) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Janus Kinase inhibitors (JAKi) Market Facts & Figures by Country
3.8.1 Middle East and Africa Janus Kinase inhibitors (JAKi) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Janus Kinase inhibitors (JAKi) Sales by Type (2021–2032)
4.1.1 Global Janus Kinase inhibitors (JAKi) Sales by Type (2021–2026)
4.1.2 Global Janus Kinase inhibitors (JAKi) Sales by Type (2027–2032)
4.1.3 Global Janus Kinase inhibitors (JAKi) Sales Market Share by Type (2021–2032)
4.2 Global Janus Kinase inhibitors (JAKi) Revenue by Type (2021–2032)
4.2.1 Global Janus Kinase inhibitors (JAKi) Revenue by Type (2021–2026)
4.2.2 Global Janus Kinase inhibitors (JAKi) Revenue by Type (2027–2032)
4.2.3 Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Type (2021–2032)
4.3 Global Janus Kinase inhibitors (JAKi) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Janus Kinase inhibitors (JAKi) Sales by Application (2021–2032)
5.1.1 Global Janus Kinase inhibitors (JAKi) Sales by Application (2021–2026)
5.1.2 Global Janus Kinase inhibitors (JAKi) Sales by Application (2027–2032)
5.1.3 Global Janus Kinase inhibitors (JAKi) Sales Market Share by Application (2021–2032)
5.2 Global Janus Kinase inhibitors (JAKi) Revenue by Application (2021–2032)
5.2.1 Global Janus Kinase inhibitors (JAKi) Revenue by Application (2021–2026)
5.2.2 Global Janus Kinase inhibitors (JAKi) Revenue by Application (2027–2032)
5.2.3 Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Application (2021–2032)
5.3 Global Janus Kinase inhibitors (JAKi) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Eli Lilly and Co.
6.1.1 Eli Lilly and Co. Company Information
6.1.2 Eli Lilly and Co. Description and Business Overview
6.1.3 Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Product Portfolio
6.1.5 Eli Lilly and Co. Recent Developments/Updates
6.2 Pfizer Inc.
6.2.1 Pfizer Inc. Company Information
6.2.2 Pfizer Inc. Description and Business Overview
6.2.3 Pfizer Inc. Janus Kinase inhibitors (JAKi) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pfizer Inc. Janus Kinase inhibitors (JAKi) Product Portfolio
6.2.5 Pfizer Inc. Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Company Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Janus Kinase inhibitors (JAKi) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 AbbVie Janus Kinase inhibitors (JAKi) Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Galapagos NV
6.4.1 Galapagos NV Company Information
6.4.2 Galapagos NV Description and Business Overview
6.4.3 Galapagos NV Janus Kinase inhibitors (JAKi) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Galapagos NV Janus Kinase inhibitors (JAKi) Product Portfolio
6.4.5 Galapagos NV Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Janus Kinase inhibitors (JAKi) Industry Chain Analysis
7.2 Janus Kinase inhibitors (JAKi) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Janus Kinase inhibitors (JAKi) Production Mode & Process Analysis
7.4 Janus Kinase inhibitors (JAKi) Sales and Marketing
7.4.1 Janus Kinase inhibitors (JAKi) Sales Channels
7.4.2 Janus Kinase inhibitors (JAKi) Distributors
7.5 Janus Kinase inhibitors (JAKi) Customer Analysis
8 Janus Kinase inhibitors (JAKi) Market Dynamics
8.1 Janus Kinase inhibitors (JAKi) Industry Trends
8.2 Janus Kinase inhibitors (JAKi) Market Drivers
8.3 Janus Kinase inhibitors (JAKi) Market Challenges
8.4 Janus Kinase inhibitors (JAKi) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Janus Kinase inhibitors (JAKi) Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Janus Kinase inhibitors (JAKi) Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Janus Kinase inhibitors (JAKi) Market Competitive Situation by Manufacturers in 2025
Table 4. Global Janus Kinase inhibitors (JAKi) Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Janus Kinase inhibitors (JAKi) Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Janus Kinase inhibitors (JAKi) Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Janus Kinase inhibitors (JAKi) Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Janus Kinase inhibitors (JAKi), Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Janus Kinase inhibitors (JAKi), Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Janus Kinase inhibitors (JAKi), Product Types and Applications
Table 12. Global Key Manufacturers of Janus Kinase inhibitors (JAKi), Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Janus Kinase inhibitors (JAKi) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Janus Kinase inhibitors (JAKi) Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Janus Kinase inhibitors (JAKi) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Janus Kinase inhibitors (JAKi) Sales by Region (K Units), 2021–2026
Table 18. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Region (2021–2026)
Table 19. Global Janus Kinase inhibitors (JAKi) Sales by Region (K Units), 2027–2032
Table 20. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Region (2027–2032)
Table 21. Global Janus Kinase inhibitors (JAKi) Revenue by Region (US$ Million), 2021–2026
Table 22. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Region (2021–2026)
Table 23. Global Janus Kinase inhibitors (JAKi) Revenue by Region (US$ Million), 2027–2032
Table 24. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Region (2027–2032)
Table 25. North America Janus Kinase inhibitors (JAKi) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Janus Kinase inhibitors (JAKi) Sales by Country (K Units), 2021–2026
Table 27. North America Janus Kinase inhibitors (JAKi) Sales by Country (K Units), 2027–2032
Table 28. North America Janus Kinase inhibitors (JAKi) Revenue by Country (US$ Million), 2021–2026
Table 29. North America Janus Kinase inhibitors (JAKi) Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Janus Kinase inhibitors (JAKi) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Janus Kinase inhibitors (JAKi) Sales by Country (K Units), 2021–2026
Table 32. Europe Janus Kinase inhibitors (JAKi) Sales by Country (K Units), 2027–2032
Table 33. Europe Janus Kinase inhibitors (JAKi) Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Janus Kinase inhibitors (JAKi) Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Janus Kinase inhibitors (JAKi) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Janus Kinase inhibitors (JAKi) Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Janus Kinase inhibitors (JAKi) Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Janus Kinase inhibitors (JAKi) Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Janus Kinase inhibitors (JAKi) Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Janus Kinase inhibitors (JAKi) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Janus Kinase inhibitors (JAKi) Sales by Country (K Units), 2021–2026
Table 42. Latin America Janus Kinase inhibitors (JAKi) Sales by Country (K Units), 2027–2032
Table 43. Latin America Janus Kinase inhibitors (JAKi) Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Janus Kinase inhibitors (JAKi) Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue by Country (US$ Million), 2027–2032
Table 50. Global Janus Kinase inhibitors (JAKi) Sales (K Units) by Type (2021–2026)
Table 51. Global Janus Kinase inhibitors (JAKi) Sales (K Units) by Type (2027–2032)
Table 52. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Type (2021–2026)
Table 53. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Type (2027–2032)
Table 54. Global Janus Kinase inhibitors (JAKi) Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Janus Kinase inhibitors (JAKi) Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Type (2021–2026)
Table 57. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Type (2027–2032)
Table 58. Global Janus Kinase inhibitors (JAKi) Price (US$/Unit) by Type (2021–2026)
Table 59. Global Janus Kinase inhibitors (JAKi) Price (US$/Unit) by Type (2027–2032)
Table 60. Global Janus Kinase inhibitors (JAKi) Sales (K Units) by Application (2021–2026)
Table 61. Global Janus Kinase inhibitors (JAKi) Sales (K Units) by Application (2027–2032)
Table 62. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Application (2021–2026)
Table 63. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Application (2027–2032)
Table 64. Global Janus Kinase inhibitors (JAKi) Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Janus Kinase inhibitors (JAKi) Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Application (2021–2026)
Table 67. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Application (2027–2032)
Table 68. Global Janus Kinase inhibitors (JAKi) Price (US$/Unit) by Application (2021–2026)
Table 69. Global Janus Kinase inhibitors (JAKi) Price (US$/Unit) by Application (2027–2032)
Table 70. Eli Lilly and Co. Company Information
Table 71. Eli Lilly and Co. Description and Business Overview
Table 72. Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Product
Table 74. Eli Lilly and Co. Recent Developments/Updates
Table 75. Pfizer Inc. Company Information
Table 76. Pfizer Inc. Description and Business Overview
Table 77. Pfizer Inc. Janus Kinase inhibitors (JAKi) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Pfizer Inc. Janus Kinase inhibitors (JAKi) Product
Table 79. Pfizer Inc. Recent Developments/Updates
Table 80. AbbVie Company Information
Table 81. AbbVie Description and Business Overview
Table 82. AbbVie Janus Kinase inhibitors (JAKi) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. AbbVie Janus Kinase inhibitors (JAKi) Product
Table 84. AbbVie Recent Developments/Updates
Table 85. Galapagos NV Company Information
Table 86. Galapagos NV Description and Business Overview
Table 87. Galapagos NV Janus Kinase inhibitors (JAKi) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Galapagos NV Janus Kinase inhibitors (JAKi) Product
Table 89. Galapagos NV Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Janus Kinase inhibitors (JAKi) Distributors List
Table 93. Janus Kinase inhibitors (JAKi) Customers List
Table 94. Janus Kinase inhibitors (JAKi) Market Trends
Table 95. Janus Kinase inhibitors (JAKi) Market Drivers
Table 96. Janus Kinase inhibitors (JAKi) Market Challenges
Table 97. Janus Kinase inhibitors (JAKi) Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Janus Kinase inhibitors (JAKi)
Figure 2. Global Janus Kinase inhibitors (JAKi) Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Janus Kinase inhibitors (JAKi) Market Share by Type: 2025 & 2032
Figure 4. Tofacitinib Product Picture
Figure 5. Abrocitinib Product Picture
Figure 6. Baricitinib Product Picture
Figure 7. Upadacitinib Product Picture
Figure 8. Filgotinib Product Picture
Figure 9. Global Janus Kinase inhibitors (JAKi) Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Janus Kinase inhibitors (JAKi) Market Share by Application: 2025 & 2032
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Other
Figure 14. Global Janus Kinase inhibitors (JAKi) Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Janus Kinase inhibitors (JAKi) Market Size (US$ Million), 2021–2032
Figure 16. Global Janus Kinase inhibitors (JAKi) Sales (K Units), 2021–2032
Figure 17. Global Janus Kinase inhibitors (JAKi) Average Price (US$/Unit), 2021–2032
Figure 18. Janus Kinase inhibitors (JAKi) Report Years Considered
Figure 19. Janus Kinase inhibitors (JAKi) Sales Share by Manufacturers in 2025
Figure 20. Global Janus Kinase inhibitors (JAKi) Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Janus Kinase inhibitors (JAKi) Players: Market Share by Revenue in Janus Kinase inhibitors (JAKi) in 2025
Figure 22. Janus Kinase inhibitors (JAKi) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Janus Kinase inhibitors (JAKi) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2021–2032)
Figure 25. North America Janus Kinase inhibitors (JAKi) Revenue Market Share by Country (2021–2032)
Figure 26. United States Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2021–2032)
Figure 29. Europe Janus Kinase inhibitors (JAKi) Revenue Market Share by Country (2021–2032)
Figure 30. Germany Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Janus Kinase inhibitors (JAKi) Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Janus Kinase inhibitors (JAKi) Revenue Market Share by Region (2021–2032)
Figure 37. China Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2021–2032)
Figure 45. Latin America Janus Kinase inhibitors (JAKi) Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Janus Kinase inhibitors (JAKi) by Type (2021–2032)
Figure 56. Global Revenue Market Share of Janus Kinase inhibitors (JAKi) by Type (2021–2032)
Figure 57. Global Janus Kinase inhibitors (JAKi) Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Janus Kinase inhibitors (JAKi) by Application (2021–2032)
Figure 59. Global Revenue Market Share of Janus Kinase inhibitors (JAKi) by Application (2021–2032)
Figure 60. Global Janus Kinase inhibitors (JAKi) Price (US$/Unit) by Application (2021–2032)
Figure 61. Janus Kinase inhibitors (JAKi) Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Janus Kinase inhibitors (JAKi) Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Janus Kinase inhibitors (JAKi) Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Janus Kinase inhibitors (JAKi) Market Competitive Situation by Manufacturers in 2025
Table 4. Global Janus Kinase inhibitors (JAKi) Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Janus Kinase inhibitors (JAKi) Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Janus Kinase inhibitors (JAKi) Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Janus Kinase inhibitors (JAKi) Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Janus Kinase inhibitors (JAKi), Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Janus Kinase inhibitors (JAKi), Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Janus Kinase inhibitors (JAKi), Product Types and Applications
Table 12. Global Key Manufacturers of Janus Kinase inhibitors (JAKi), Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Janus Kinase inhibitors (JAKi) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Janus Kinase inhibitors (JAKi) Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Janus Kinase inhibitors (JAKi) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Janus Kinase inhibitors (JAKi) Sales by Region (K Units), 2021–2026
Table 18. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Region (2021–2026)
Table 19. Global Janus Kinase inhibitors (JAKi) Sales by Region (K Units), 2027–2032
Table 20. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Region (2027–2032)
Table 21. Global Janus Kinase inhibitors (JAKi) Revenue by Region (US$ Million), 2021–2026
Table 22. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Region (2021–2026)
Table 23. Global Janus Kinase inhibitors (JAKi) Revenue by Region (US$ Million), 2027–2032
Table 24. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Region (2027–2032)
Table 25. North America Janus Kinase inhibitors (JAKi) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Janus Kinase inhibitors (JAKi) Sales by Country (K Units), 2021–2026
Table 27. North America Janus Kinase inhibitors (JAKi) Sales by Country (K Units), 2027–2032
Table 28. North America Janus Kinase inhibitors (JAKi) Revenue by Country (US$ Million), 2021–2026
Table 29. North America Janus Kinase inhibitors (JAKi) Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Janus Kinase inhibitors (JAKi) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Janus Kinase inhibitors (JAKi) Sales by Country (K Units), 2021–2026
Table 32. Europe Janus Kinase inhibitors (JAKi) Sales by Country (K Units), 2027–2032
Table 33. Europe Janus Kinase inhibitors (JAKi) Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Janus Kinase inhibitors (JAKi) Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Janus Kinase inhibitors (JAKi) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Janus Kinase inhibitors (JAKi) Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Janus Kinase inhibitors (JAKi) Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Janus Kinase inhibitors (JAKi) Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Janus Kinase inhibitors (JAKi) Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Janus Kinase inhibitors (JAKi) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Janus Kinase inhibitors (JAKi) Sales by Country (K Units), 2021–2026
Table 42. Latin America Janus Kinase inhibitors (JAKi) Sales by Country (K Units), 2027–2032
Table 43. Latin America Janus Kinase inhibitors (JAKi) Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Janus Kinase inhibitors (JAKi) Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue by Country (US$ Million), 2027–2032
Table 50. Global Janus Kinase inhibitors (JAKi) Sales (K Units) by Type (2021–2026)
Table 51. Global Janus Kinase inhibitors (JAKi) Sales (K Units) by Type (2027–2032)
Table 52. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Type (2021–2026)
Table 53. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Type (2027–2032)
Table 54. Global Janus Kinase inhibitors (JAKi) Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Janus Kinase inhibitors (JAKi) Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Type (2021–2026)
Table 57. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Type (2027–2032)
Table 58. Global Janus Kinase inhibitors (JAKi) Price (US$/Unit) by Type (2021–2026)
Table 59. Global Janus Kinase inhibitors (JAKi) Price (US$/Unit) by Type (2027–2032)
Table 60. Global Janus Kinase inhibitors (JAKi) Sales (K Units) by Application (2021–2026)
Table 61. Global Janus Kinase inhibitors (JAKi) Sales (K Units) by Application (2027–2032)
Table 62. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Application (2021–2026)
Table 63. Global Janus Kinase inhibitors (JAKi) Sales Market Share by Application (2027–2032)
Table 64. Global Janus Kinase inhibitors (JAKi) Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Janus Kinase inhibitors (JAKi) Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Application (2021–2026)
Table 67. Global Janus Kinase inhibitors (JAKi) Revenue Market Share by Application (2027–2032)
Table 68. Global Janus Kinase inhibitors (JAKi) Price (US$/Unit) by Application (2021–2026)
Table 69. Global Janus Kinase inhibitors (JAKi) Price (US$/Unit) by Application (2027–2032)
Table 70. Eli Lilly and Co. Company Information
Table 71. Eli Lilly and Co. Description and Business Overview
Table 72. Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Eli Lilly and Co. Janus Kinase inhibitors (JAKi) Product
Table 74. Eli Lilly and Co. Recent Developments/Updates
Table 75. Pfizer Inc. Company Information
Table 76. Pfizer Inc. Description and Business Overview
Table 77. Pfizer Inc. Janus Kinase inhibitors (JAKi) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Pfizer Inc. Janus Kinase inhibitors (JAKi) Product
Table 79. Pfizer Inc. Recent Developments/Updates
Table 80. AbbVie Company Information
Table 81. AbbVie Description and Business Overview
Table 82. AbbVie Janus Kinase inhibitors (JAKi) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. AbbVie Janus Kinase inhibitors (JAKi) Product
Table 84. AbbVie Recent Developments/Updates
Table 85. Galapagos NV Company Information
Table 86. Galapagos NV Description and Business Overview
Table 87. Galapagos NV Janus Kinase inhibitors (JAKi) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Galapagos NV Janus Kinase inhibitors (JAKi) Product
Table 89. Galapagos NV Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Janus Kinase inhibitors (JAKi) Distributors List
Table 93. Janus Kinase inhibitors (JAKi) Customers List
Table 94. Janus Kinase inhibitors (JAKi) Market Trends
Table 95. Janus Kinase inhibitors (JAKi) Market Drivers
Table 96. Janus Kinase inhibitors (JAKi) Market Challenges
Table 97. Janus Kinase inhibitors (JAKi) Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Janus Kinase inhibitors (JAKi)
Figure 2. Global Janus Kinase inhibitors (JAKi) Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Janus Kinase inhibitors (JAKi) Market Share by Type: 2025 & 2032
Figure 4. Tofacitinib Product Picture
Figure 5. Abrocitinib Product Picture
Figure 6. Baricitinib Product Picture
Figure 7. Upadacitinib Product Picture
Figure 8. Filgotinib Product Picture
Figure 9. Global Janus Kinase inhibitors (JAKi) Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Janus Kinase inhibitors (JAKi) Market Share by Application: 2025 & 2032
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Other
Figure 14. Global Janus Kinase inhibitors (JAKi) Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Janus Kinase inhibitors (JAKi) Market Size (US$ Million), 2021–2032
Figure 16. Global Janus Kinase inhibitors (JAKi) Sales (K Units), 2021–2032
Figure 17. Global Janus Kinase inhibitors (JAKi) Average Price (US$/Unit), 2021–2032
Figure 18. Janus Kinase inhibitors (JAKi) Report Years Considered
Figure 19. Janus Kinase inhibitors (JAKi) Sales Share by Manufacturers in 2025
Figure 20. Global Janus Kinase inhibitors (JAKi) Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Janus Kinase inhibitors (JAKi) Players: Market Share by Revenue in Janus Kinase inhibitors (JAKi) in 2025
Figure 22. Janus Kinase inhibitors (JAKi) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Janus Kinase inhibitors (JAKi) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2021–2032)
Figure 25. North America Janus Kinase inhibitors (JAKi) Revenue Market Share by Country (2021–2032)
Figure 26. United States Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2021–2032)
Figure 29. Europe Janus Kinase inhibitors (JAKi) Revenue Market Share by Country (2021–2032)
Figure 30. Germany Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Janus Kinase inhibitors (JAKi) Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Janus Kinase inhibitors (JAKi) Revenue Market Share by Region (2021–2032)
Figure 37. China Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2021–2032)
Figure 45. Latin America Janus Kinase inhibitors (JAKi) Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Janus Kinase inhibitors (JAKi) Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Janus Kinase inhibitors (JAKi) Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Janus Kinase inhibitors (JAKi) Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Janus Kinase inhibitors (JAKi) by Type (2021–2032)
Figure 56. Global Revenue Market Share of Janus Kinase inhibitors (JAKi) by Type (2021–2032)
Figure 57. Global Janus Kinase inhibitors (JAKi) Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Janus Kinase inhibitors (JAKi) by Application (2021–2032)
Figure 59. Global Revenue Market Share of Janus Kinase inhibitors (JAKi) by Application (2021–2032)
Figure 60. Global Janus Kinase inhibitors (JAKi) Price (US$/Unit) by Application (2021–2032)
Figure 61. Janus Kinase inhibitors (JAKi) Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232